HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma (Q46494095)

22 December 2017

title

HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma (English)

1 reference

22 December 2017

1 reference

Thiyam Ramsing Singh

1

1 reference

22 December 2017

Sharmila Shankar

series ordinal

2

1 reference

22 December 2017

Rakesh K Srivastava

series ordinal

3

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

22 December 2017

published in

Oncogene

1 reference

22 December 2017

volume

24

1 reference

22 December 2017

issue

29

1 reference

22 December 2017

page(s)

4609-4623

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208585

exact match

0 references

cites work

Apoptosis control by death and decoy receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

MC159L protein from the poxvirus molluscum contagiosum virus inhibits NF-kappaB activation and apoptosis induced by PKR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

The human histone deacetylase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

Sensitization of human colon cancer cells to TRAIL-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

Livin, a novel inhibitor of apoptosis protein family member

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

Histone deacetylase inhibitors as new cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

Sensitization of mesothelioma to TRAIL apoptosis by inhibition of histone deacetylase: role of Bcl-xL down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

Structure—Function Analysis of Bcl-2 Family Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

BAX and BAK mediate p53-independent suppression of tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

X-linked IAP is a direct inhibitor of cell-death proteases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Isobolographic analysis of interactions: an update on applications and utility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Mitochondria and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

BCL-2 family members and the mitochondria in apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Role of the histone deacetylase complex in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Deacetylation of p53 modulates its effect on cell growth and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Programmed cell death and the caspases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

TRAIL/Apo-2L: mechanisms and clinical applications in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Bcl-2 and Bcl-X(L) block thapsigargin-induced nitric oxide generation, c-Jun NH(2)-terminal kinase activity, and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

The language of covalent histone modifications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

The interaction index: a measure of drug synergism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208585

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208585

1 reference

22 December 2017

PubMed ID

15897906

1 reference

22 December 2017